September 23: The Week in Cancer News
Genetic tests create opportunities but also confusion for breast cancer patients, and more from the week in cancer news.
Progress Against Cancer
Genetic tests create opportunities but also confusion for breast cancer patients, and more from the week in cancer news.
Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
A new study adds nuance to the ‘golden age’ of cancer drug approvals.
COVID-19 boosters promote immune response in additional blood cancer patients, and high drug costs lead cancer patients to not fill prescriptions.
People in treatment for early-stage cancer should try to get exercise, according to new recommendations.
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are relatively rare. However, these cancers lead to death in approximately 35 percent of patients diagnosed...
Motherhood does not decrease chance of survival for women who have had breast cancer, and other stories from the week in cancer news.
Colorectal cancer screening less prevalent in the younger end of the recommended age group, and cancer patients targeted online with ads for unproven treatment.
Screenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More